Key Head & Neck Journal Articles
Published: Fri Apr 29, 2011 Updated:Thu Oct 13, 2011
-
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Wells Jr SA et al; October 24, 2011; JCO.2011.35.5040
-
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study
Urba S. et al; March 20th, 2012; doi: 10.1002/cncr.27449
-
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial
Bourhis J. et al; February 13th, 2012;(2):145-53. Epub 2012 Jan 18.
-
Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer
Yeh SH et al; March 15th, 2012; 82(4):1463-70. Epub 2011 Aug 11.
-
Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer
Gilbert J et al; February 15, 2012; doi: 10.1002/cncr.26364
-
Podcast: ESMO 2011 Interview with Dr Camilla Hoff on the influence of smoking in patients with squamous cell carcinoma of the head and neck
C Hoff et al; October 4, 2011; ESMO 2011
-
Early Trial Supports Bevacizumab in Head and Neck Cancer
N Osterweil, et al; October 18, 2011; Oncology Practice
-
Thyroid cancer patients’ involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study
AM Sawka, et al; April 28, 2011; DOI: 10.1007/s00520-011-1302-x
-
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
QY Chen, et al; September 27, 2011; doi: 10.1093/jnci/djr432
-
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease
M Hamoir et al; October 3, 2011; doi:10.1016/j.oraloncology.2011.10.015
-
Clinical significance of micrometastases in lymph nodes from laryngeal squamous cell carcinoma
X Yanan et al; July 4th, 2011; doi:10.1016/j.amjoto.2011.10.012
-
Exploring novel therapeutic strategies for cetuximab in head and neck squamous cell carcinoma
EJCMO 2011; 3, 25-31
-
New Guidelines for Reirradiation of Head and Neck Cancer
Oral Cancer News, 2011
-
Podcast: ESMO 2011 Interview with Professor Jan Vermorken analyzing the results of the phase III SPECTRUM trial
J Vermorken et al; ESMO 2011
-
HPV and Head and Neck Cancer
Nicholas J. Sanfilippo, MD
-
Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer
FF Mohammed et al, Sep 26, 2011; DOI: 10.1002/hed.21848
-
Anti-EGFR–targeting agents in recurrent or metastatic head and neck carcinoma: A meta-analysis
F Petrelli et al, Sep 23, 2011; DOI: 10.1002/hed.21858
-
Circulating Tumor Cell Assay Shows Potential for Predicting Prognosis in Head and Neck Carcinoma
M Stenger et al, Sep 1, 2011; Volume 2, Issue 13
-
Population-Based Study of Competing Mortality in Head and Neck Cancer
B S Rose et al, Aug 15, 2011; doi: 10.1200/JCO.2011.37.1393
-
Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma
D I Pryor et al, May 24, 2011; doi:10.1016/j.oraloncology.2011.07.023
-
Does PEG Use Cause Dysphagia in Head and Neck Cancer Patients?
S Langmore et al, Feb 14, 2011; DOI: 10.1007/s00455-011-9360-2Online First
-
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer Article Review by Dr Snow
K Kian Ang et al, NEJM. Jul 1 2010; 363:24-35
-
Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study
CN Chu et al; Sept 13, 2011; doi:10.1038/bjc.2011.361
-
Radiotherapy plus Cetuximab for Squamous- Cell Carcinoma of the Head and Neck
JA Bonner et al, N Engl J Med 2006;354:567-78
-
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
JB Vermorken et al. N Engl J Med 2008;359:1116-27
-
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
JP Pignon et al, 2009 Jul; 92(1):4-14, doi:10.1016/j.radonc.2009.04.01
-
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
J Bourhis et al, Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD002026. DOI: 10.1002/14651858.CD002026.pub2
-
A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy
MG Isles et al, Clin Otolaryngol. 2008 Jun;33(3):210-22
